234 related articles for article (PubMed ID: 35197475)
1. Integrative molecular and clinical profiling of acral melanoma links focal amplification of 22q11.21 to metastasis.
Farshidfar F; Rhrissorrakrai K; Levovitz C; Peng C; Knight J; Bacchiocchi A; Su J; Yin M; Sznol M; Ariyan S; Clune J; Olino K; Parida L; Nikolaus J; Zhang M; Zhao S; Wang Y; Huang G; Wan M; Li X; Cao J; Yan Q; Chen X; Newman AM; Halaban R
Nat Commun; 2022 Feb; 13(1):898. PubMed ID: 35197475
[TBL] [Abstract][Full Text] [Related]
2. Integrated genomic analyses of acral and mucosal melanomas nominate novel driver genes.
Wang M; Banik I; Shain AH; Yeh I; Bastian BC
Genome Med; 2022 Jun; 14(1):65. PubMed ID: 35706047
[TBL] [Abstract][Full Text] [Related]
3. Targeted Genomic Profiling of Acral Melanoma.
Yeh I; Jorgenson E; Shen L; Xu M; North JP; Shain AH; Reuss D; Wu H; Robinson WA; Olshen A; von Deimling A; Kwok PY; Bastian BC; Asgari MM
J Natl Cancer Inst; 2019 Oct; 111(10):1068-1077. PubMed ID: 30657954
[TBL] [Abstract][Full Text] [Related]
4. Integrative Genomic Profiling Uncovers Therapeutic Targets of Acral Melanoma in Asian Populations.
Shi Q; Liu L; Chen J; Zhang W; Guo W; Wang X; Wang H; Guo S; Yue Q; Ma J; Liu Y; Zhu G; Zhao T; Zhao J; Liu Y; Gao T; Li C
Clin Cancer Res; 2022 Jun; 28(12):2690-2703. PubMed ID: 35294533
[TBL] [Abstract][Full Text] [Related]
5. NUAK2: an emerging acral melanoma oncogene.
Namiki T; Coelho SG; Hearing VJ
Oncotarget; 2011 Sep; 2(9):695-704. PubMed ID: 21911917
[TBL] [Abstract][Full Text] [Related]
6. Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin.
Bastian BC; Kashani-Sabet M; Hamm H; Godfrey T; Moore DH; Bröcker EB; LeBoit PE; Pinkel D
Cancer Res; 2000 Apr; 60(7):1968-73. PubMed ID: 10766187
[TBL] [Abstract][Full Text] [Related]
7. Cyclin D1 is a candidate oncogene in cutaneous melanoma.
Sauter ER; Yeo UC; von Stemm A; Zhu W; Litwin S; Tichansky DS; Pistritto G; Nesbit M; Pinkel D; Herlyn M; Bastian BC
Cancer Res; 2002 Jun; 62(11):3200-6. PubMed ID: 12036934
[TBL] [Abstract][Full Text] [Related]
8. Clinical and genetic analysis of melanomas arising in acral sites.
Zaremba A; Murali R; Jansen P; Möller I; Sucker A; Paschen A; Zimmer L; Livingstone E; Brinker TJ; Hadaschik E; Franklin C; Roesch A; Ugurel S; Schadendorf D; Griewank KG; Cosgarea I
Eur J Cancer; 2019 Sep; 119():66-76. PubMed ID: 31419753
[TBL] [Abstract][Full Text] [Related]
9. Anatomic position determines oncogenic specificity in melanoma.
Weiss JM; Hunter MV; Cruz NM; Baggiolini A; Tagore M; Ma Y; Misale S; Marasco M; Simon-Vermot T; Campbell NR; Newell F; Wilmott JS; Johansson PA; Thompson JF; Long GV; Pearson JV; Mann GJ; Scolyer RA; Waddell N; Montal ED; Huang TH; Jonsson P; Donoghue MTA; Harris CC; Taylor BS; Xu T; Chaligné R; Shliaha PV; Hendrickson R; Jungbluth AA; Lezcano C; Koche R; Studer L; Ariyan CE; Solit DB; Wolchok JD; Merghoub T; Rosen N; Hayward NK; White RM
Nature; 2022 Apr; 604(7905):354-361. PubMed ID: 35355015
[TBL] [Abstract][Full Text] [Related]
10. Acral lentiginous melanoma: Basic facts, biological characteristics and research perspectives of an understudied disease.
Basurto-Lozada P; Molina-Aguilar C; Castaneda-Garcia C; Vázquez-Cruz ME; Garcia-Salinas OI; Álvarez-Cano A; Martínez-Said H; Roldán-Marín R; Adams DJ; Possik PA; Robles-Espinoza CD
Pigment Cell Melanoma Res; 2021 Jan; 34(1):59-71. PubMed ID: 32330367
[TBL] [Abstract][Full Text] [Related]
11. Distinct genomic traits of acral and mucosal melanomas revealed by targeted mutational profiling.
Zou Z; Ou Q; Ren Y; Lv Q; Qin L; Zhao L; Su S; Wu X; Bao H; Wang A; Zhu D; Wang X; Shao YW; Liu B
Pigment Cell Melanoma Res; 2020 Jul; 33(4):601-611. PubMed ID: 31944535
[TBL] [Abstract][Full Text] [Related]
12. Does the morphology of cutaneous melanoma help to explain the international differences in survival? Results from 1 578 482 adults diagnosed during 2000-2014 in 59 countries (CONCORD-3).
Di Carlo V; Stiller CA; Eisemann N; Bordoni A; Matz M; Curado MP; Daubisse-Marliac L; Valkov M; Bulliard JL; Morrison D; Johnson C; Girardi F; Marcos-Gragera R; Šekerija M; Larønningen S; Sirri E; Coleman MP; Allemani C;
Br J Dermatol; 2022 Sep; 187(3):364-380. PubMed ID: 35347700
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of anti-PD-1 agents in acral and mucosal melanoma.
Shoushtari AN; Munhoz RR; Kuk D; Ott PA; Johnson DB; Tsai KK; Rapisuwon S; Eroglu Z; Sullivan RJ; Luke JJ; Gangadhar TC; Salama AK; Clark V; Burias C; Puzanov I; Atkins MB; Algazi AP; Ribas A; Wolchok JD; Postow MA
Cancer; 2016 Nov; 122(21):3354-3362. PubMed ID: 27533633
[TBL] [Abstract][Full Text] [Related]
14. Clinical and molecular features of subungual melanomas are site-specific and distinct from acral melanomas.
Holman BN; Van Gulick RJ; Amato CM; MacBeth ML; Davies KD; Aisner DL; Robinson WA; Couts KL
Melanoma Res; 2020 Dec; 30(6):562-573. PubMed ID: 33156595
[TBL] [Abstract][Full Text] [Related]
15. Distinct Patterns of Acral Melanoma Based on Site and Relative Sun Exposure.
Haugh AM; Zhang B; Quan VL; Garfield EM; Bubley JA; Kudalkar E; Verzi AE; Walton K; VandenBoom T; Merkel EA; Lee CY; Tan T; Isales MC; Kong BY; Wenzel AT; Bunick CG; Choi J; Sosman J; Gerami P
J Invest Dermatol; 2018 Feb; 138(2):384-393. PubMed ID: 28870692
[TBL] [Abstract][Full Text] [Related]
16. GAB2 amplifications refine molecular classification of melanoma.
Chernoff KA; Bordone L; Horst B; Simon K; Twadell W; Lee K; Cohen JA; Wang S; Silvers DN; Brunner G; Celebi JT
Clin Cancer Res; 2009 Jul; 15(13):4288-91. PubMed ID: 19509136
[TBL] [Abstract][Full Text] [Related]
17. Clinical features, molecular pathology, and immune microenvironmental characteristics of acral melanoma.
Gui J; Guo Z; Wu D
J Transl Med; 2022 Aug; 20(1):367. PubMed ID: 35974375
[TBL] [Abstract][Full Text] [Related]
18. Specific dermoscopy patterns and amplifications of the cyclin D1 gene to define histopathologically unrecognizable early lesions of acral melanoma in situ.
Yamaura M; Takata M; Miyazaki A; Saida T
Arch Dermatol; 2005 Nov; 141(11):1413-8. PubMed ID: 16301388
[TBL] [Abstract][Full Text] [Related]
19. Benefit and toxicity of programmed death-1 blockade vary by ethnicity in patients with advanced melanoma: an international multicentre observational study.
Bai X; Shoushtari AN; Betof Warner A; Si L; Tang B; Cui C; Yang X; Wei X; Quach HT; Cann CG; Zhang MZ; Pallan L; Harvey C; Kim MS; Kasumova G; Sharova T; Cohen JV; Lawrence DP; Freedman C; Fadden RM; Rubin KM; Frederick DT; Flaherty KT; Long GV; Menzies AM; Sullivan RJ; Boland GM; Johnson DB; Guo J
Br J Dermatol; 2022 Sep; 187(3):401-410. PubMed ID: 35293617
[TBL] [Abstract][Full Text] [Related]
20. Characterizations of Gene Alterations in Melanoma Patients from Chinese Population.
Luo Y; Zhang Z; Liu J; Li L; Xu X; Yao X; Dai Z; Wang X; Yang S; Wu H; Bu J; Wu Y; Xiang T; Li X
Biomed Res Int; 2020; 2020():6096814. PubMed ID: 32083130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
